Results of SWOG 1318: A phase 2 trial of blinatumomab followed by POMP (prednisone, vincristine, methotrexate, 6-mercaptopurine) maintenance in elderly patients with newly diagnosed Philadelphia chromosome negative B-cell acute lymphoblastic leukemia Meeting Abstract
| Authors: | Advani, A. S.; Moseley, A.; O'Dwyer, K. M.; Wood, B.; Fang, M.; Wieduwilt, M. J.; Aldoss, I.; Park, J. H.; Klisovic, R.; Baer, M. R.; Stock, W.; Bhave, R.; Othus, M.; Litzow, M. R.; Stone, R. M.; Erba, H. P. |
| Abstract Title: | Results of SWOG 1318: A phase 2 trial of blinatumomab followed by POMP (prednisone, vincristine, methotrexate, 6-mercaptopurine) maintenance in elderly patients with newly diagnosed Philadelphia chromosome negative B-cell acute lymphoblastic leukemia |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837600087 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-111992 |
| Notes: | Meeting Abstract: 33 -- Source: Wos |
